NDC Package 50242-007-86 Enspryng

Satralizumab Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

50242-007-86

Package Description:

1 SYRINGE, PLASTIC in 1 CARTON / 1 mL in 1 SYRINGE, PLASTIC

Product Code:

50242-007

Proprietary Name:

Enspryng

Non-Proprietary Name:

Satralizumab

Substance Name:

Satralizumab

Usage Information:

ENSPRYNG is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.

11-Digit NDC Billing Format:

50242000786

NDC to RxNorm Crosswalk:

RxCUI: 2391555 - satralizumab-mwge 120 MG in 1 ML Prefilled Syringe

RxCUI: 2391555 - 1 ML satralizumab-mwge 120 MG/ML Prefilled Syringe

RxCUI: 2391555 - satralizumab-mwge 120 MG per 1 ML Prefilled Syringe

RxCUI: 2391560 - Enspryng 120 MG in 1 ML Prefilled Syringe

RxCUI: 2391560 - 1 ML satralizumab-mwge 120 MG/ML Prefilled Syringe [Enspryng]

Product Type:

Human Prescription Drug

Labeler Name:

Genentech Inc.

Dosage Form:

Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.

Administration Route(s):

Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.

Active Ingredient(s):

SATRALIZUMAB 120 mg/mL

Sample Package:

Yes

FDA Application Number:

BLA761149

Marketing Category:

BLA - A product marketed under an approved Biologic License Application.

Start Marketing Date:

08-14-2020

Listing Expiration Date:

12-31-2024

Exclude Flag:

Code Structure:

50242 - Genentech Inc.
- 50242-007 - Enspryng
  - 50242-007-86 - 1 SYRINGE, PLASTIC in 1 CARTON / 1 mL in 1 SYRINGE, PLASTIC

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
50242-007-01	1 SYRINGE, PLASTIC in 1 CARTON / 1 mL in 1 SYRINGE, PLASTIC

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 50242-007-86?

The NDC Packaged Code 50242-007-86 is assigned to a package of 1 syringe, plastic in 1 carton / 1 ml in 1 syringe, plastic of Enspryng, a human prescription drug labeled by Genentech Inc.. The product's dosage form is injection, solution and is administered via subcutaneous form.

Is NDC 50242-007 included in the NDC Directory?

Yes, Enspryng with product code 50242-007 is active and included in the NDC Directory. The product was first marketed by Genentech Inc. on August 14, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 50242-007-86?

The 11-digit format is 50242000786. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	50242-007-86	5-4-2	50242-0007-86

Table of Contents